Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1183-1189

  Zhang, Shuyu ^a,b   Hao, Jun ^c   Xie, Fang ^d   Hu, Xiangui ^c   Liu, Cong ^e   Tong, Jian ^a   Zhou, Jundong ^a,f   Wu, Jinchang ^a,f   Shao, Chenghao ^c  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f SUZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MICRO RNA 132; MICRO RNA 132 INHIBITOR; MICRORNA; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER CELL; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RNA METHYLATION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

EID: 79961187284     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr105     Document Type: Article

References (37)

1. Jemal,A. et al. (2009) Cancer statistics, 2009. CA Cancer J. Clin., 59, 225-249.
2. Guo,X. et al. (2005) Current diagnosis and treatment of pancreatic cancer in China. Pancreas, 31, 13-22.
3. Pliarchopoulou,K. et al. (2009) Pancreatic cancer: current and future treatment strategies. Cancer Treat. Rev., 35, 431-436.
4. Sato,N. et al. (2006) The role of epigenetic alterations in pancreatic cancer. J. Hepatobiliary Pancreat. Surg., 13, 286-295.
5. Jones,S. et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321, 1801-1806.
6. Bartel,D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
7. Kim,V.N. (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol., 6, 376-385.
8. Zhang,B. et al. (2007) MicroRNAs and their regulatory roles in animals and plants. J. Cell. Physiol., 210, 279-289.
9. Cai,Y. et al. (2009) A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics, 7, 147-154.
10. Bushati,N. et al. (2007) MicroRNA functions. Annu. Rev. Cell Dev. Biol., 23, 175-205.
11. Croce,C.M. (2009) Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet., 10, 704-714.
12. Rachagani,S. et al. (2010) MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications. Cancer Lett., 292, 8-16.
13. Grunau,C. et al. (2001) Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res., 29, EE65-E65.
14. Bloomston,M. et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, 297, 1901-1908.
15. Zhang,Y. et al. (2009) Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J. Surg., 33, 698-709.
16. Lee,E.J. et al. (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer., 120, 1046-1054.
17. Yan,L.X. et al. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 14, 2348-2360.
18. Du,Y. et al. (2009) Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J. Gastroenterol., 44, 556-561.
19. Porkka,K.P. et al. (2007) MicroRNA expression profiling in prostate cancer. Cancer Res., 67, 6130-6135.
20. Bandres,E. et al. (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer., 5, 29.
21. Magill,S.T. et al. (2010) microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc. Natl Acad. Sci. USA., 107, 20382-20387.
22. Vo,N. et al. (2005) A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl Acad. Sci. USA., 102, 16426-16431.
23. Lee,Y. et al. (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J., 21, 4663-4670.
24. Smalheiser,N.R. (2003) EST analyses predict the existence of a population of chimeric microRNA precursor-mRNA transcripts expressed in normal human and mouse tissues. Genome Biol., 4, 403.
25. Cullen,B.R. (2004) Transcription and processing of human microRNA precursors. Mol. Cell., 16, 861-865.
26. Lee,Y. et al. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J., 23, 4051-4060.
27. Borchert,G.M. et al. (2006) RNA polymerase III transcribes human micro-RNAs. Nat. Struct. Mol. Biol., 13, 1097-1101.
28. Lagos,D. et al. (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell Biol., 12, 513-519.
29. Won,J. et al. (2002) Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells. FASEB J., 16, 1943-1945.
30. Esteve,P.O. et al. (2007) Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells. J. Biol. Chem., 282, 2615-2625.
31. Anand,S. et al. (2010) MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med., 16, 909-914.
32. Sonkoly,E. et al. (2007) MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One, 2, e610.
33. Osada,S. et al. (2000) Critical role of extracellular signal-regulated kinase (ERK) phosphorylation in novel vitamin K analog-induced cell death. Jpn. J. Cancer Res., 91, 1250-1257.
34. Schlieman,M.G. et al. (2003) Incidence, mechanism and prognostic value of activated AKT in pancreas cancer. Br. J. Cancer., 89, 2110-2115.
35. Yamamoto,S. et al. (2004) Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin. Cancer Res., 10, 2846-2850.
36. Yoshida,T. et al. (2004) Development of gene therapy to target pancreatic cancer. Cancer Sci., 95, 283-289.
37. Biliran,H.Jr. et al. (2005) Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin. Cancer Res., 11, 6075-6086.